49.Crook JM, O’Callaghan CJ, Duncan G, et al. Intermitten androgen suppression for rising PSA level after radiotherapy. N Engl J Med. 367: 895-903, 2012. 50.Tombal, B., et al., Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, pha se 2 study. Lancet Oncol, 2014.